INTRODUCTION
Preterm labour and its subsequent complications makes it the most common, costly and catastrophic complication of pregnancy. 1 Preterm labour is one of the main causes of perinatal mortality and morbidity. 2 Intrauterine infection contributes to 40-50% of all preterm births. 3, 4 Systemic maternal infections and genital tract infections are known to predispose to preterm delivery. C Reactive Protein (CRP) is a protein synthesized in hepatocytes in response to infection and tissue injury. High levels of CRP in early pregnancy reflect infection or inflammation in body which may lead to preterm labour. In present study we investigated whether elevated CRP concentration in early pregnancy could predict preterm delivery.
C-reactive protein (CRP) was first described in 1930 by Tillet and Francis 5 who observed that sera from patients during acute febrile illness had the ability to precipitate the C-substance (later designated C-polysaccharide, CPS) of pneumococcal cell walls. The serum factor responsible for this reaction was defined as a "C-precipitin", and later designated "C-reactive". This protein was found to appear in the blood during a variety of reactions of tissue destruction or inflammation and has served as a useful clinical index of this process.
The exact function of CRP in vivo is not known. It is probably an early broad spectrum recognition mechanism to pathogenic microorganisms. The main role of CRP is to recognize in the plasma the potentially toxic autogenous materials released from damaged tissues, to bind to them, and thereby to detoxify them and/or facilitate their clearance. 7 CRP binds selectively to T-lymphocytes, inhibit their ability to form spontaneous rosettes with sheep erythrocytes and inhibit their response to allogenic cells in mixed lymphocyte culture reactions. By contrast, CRP does not bind to B lymphocytes, nor does it alter the Bcell functions. CRP also causes inhibition of mixed lymphocyte reactivity and generation of cytotoxic lymphocytes. 9 CRP inhibits the aggregation of human platelets stimulated by either modified human immunoglobulin or thrombin. So this property of CRP may play an important role in the control of platelet responsiveness during reaction of inflammation, defence and repair. 10 CRP is a potent activator of the classical complement pathway starting with C1q. 11 CRP, like antibodies can thus bind to ligands, opsonise materials for phagocytosis, and initiate cell damage and inflammatory reactions.
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METHODS
Three hundred and six pregnant women between 12-22 weeks of gestational age with any parity attending antenatal clinic were assessed for eligibility. Out of these, 26 women with known medical disorders were excluded. Out of remaining 280 women, 28 patients who were lost to follow up & two patients who had second trimester pregnancy loss were excluded from study ( Figure 1 ).
Figure 1: Distribution of cases according to CRP and preterm delivery.
At initial prenatal visit serum sample for CRP estimation was collected after providing detailed explanation of study to patients and taking informed consent. Laboratory estimation was done by a validated high sensitivity immune turbid metric assay by using reagent latex particle coated with goat IgG. A value of 6mg/l was taken as cut off. Women with CRP value equal or more than this level were called CRP positive and valve less than that were called CRP negative. Women were followed up to delivery. Gestational age was determined by a reliable Last Menstrual Cycle (LMP) or first trimester ultrasound. Gestational age at delivery was noted. Neonatal outcome was noted. Data was analyzed by descriptive statistics like chi-square test, p-value and odds ratio. 19, 20 It has been suggested that women in preterm labour with normal CRP levels do not require amniocentesis for the purpose of ruling out intra uterine infection. 21 Recently, elevated levels of CRP measured during gestation have been linked to adverse pregnancy outcomes such as preeclampsia and intrauterine growth restriction. 22, 23 Hvilsom et al 24 reported a significant association of elevated serum CRP levels with a nearly twofold increased risk of delivery before 37 weeks' gestation. Ghezzi et al 25 found no relation between circulating CRP levels and preterm delivery. In this study, we found that a serum CRP level of more than 6mg/L has a significant association with preterm labour with an odd ratio 2.384, 95% CI: 1:153-4.928. This result supports the Massachusetts study done in 1999-2002. They found that women with CRP level >8 mg/l had greater than 2 fold higher odds for preterm delivery.
RESULTS
Out
We also found positive association between BMI of patients and CRP positivity in early pregnancy (52.9% vs. 47.05%). Patients with other risk factors for preterm labour were more likely to be CRP positive in early pregnancy. These patients went into preterm labour more often (p=0.013) Women who were CRP positive in early pregnancy were more likely to develop adverse pregnancy outcome like IUGR (50% vs. 14.21%) in our study. Maternal CRP has been studied 26 extensively as an adjunct in the diagnosis of sub clinical infection among pregnant women with preterm labour or PROM. Studies have shown that median CRP value in normal pregnancy appear to be higher than standardized value for non pregnant individuals and CRP value is further elevated in labour. Although a chorioamniotic infection or inflammation may be associated with preterm labour and delivery, it remains unclear whether elevated CRP level is a response to infection or to labour.
CONCLUSIONS
We conclude that raised CRP level (>6mg/dl) in early pregnancy in the absence of any medical /surgical or obstetric complication can predict high likelihood of preterm labour. Oligohydramnios, IUGR, PROM also has a positive correlation with CRP. It can also be shown that neonatal outcome is less likely to be good in cases of raised CRP level as LBW, preterm delivery, septicaemia and birth asphyxia is more likely to occur. The limitation of the study lies in the fact that CRP is raised in response to both pathological as well as physiological conditions. Hence widespread applicability of CRP as a predictor of poor pregnancy and neonatal outcome needs further supportive evidence. 
